Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus

Journal of Otolaryngology

Volumn 35, Issue 6, 2006, Pages 384-386

  Kayama, Chikako ^a   Goto, Yukako ^a   Shimoya, Satoko ^a   Hasegawa, Shingo ^a   Murao, Shin Ichi ^a   Nakajo, Yoshimi ^a   Nibu, Ken Ichi ^b  

^a Konan Hospital   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gentian violet; Methicillin resistant Staphylococcus aureus; Otitis

Indexed keywords

CRYSTAL VIOLET;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; EAR INFECTION; HUMAN; INFANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REMISSION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; CHILD, PRESCHOOL; EAR DISEASES; GENTIAN VIOLET; HUMANS; INFANT; METHICILLIN RESISTANCE; MIDDLE AGED; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 33846044197     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2006.0076     Document Type: Article

References (11)

1. Suzuki K, Nishimura T, Baba S. Current status of bacterial resistance in the otolaryngology field: results from the second nationwide survey in Japan. J Infect Chemother 2003;9:46-52.
2. Walshe P, Rowley H, Timon C. A worrying development in the microbiology of otitis externa. Clin Otolaryngol 2001;26:218-20.
3. Kopstein E. Otitis externa: unorthodox but effective treatments. Laryngoscope 1984;94:1248.
4. Okano M, Noguchi S, Tabata K, Matsumoto Y. Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol 2000;39:942-4.
5. Kayama C, Goto Y, Shimoya S, et al. Effects of gentian violet on intractable infection of the ear with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. J Jpn Soc Infect Dis Otolaryngol 2003;22:130-4.
6. Tom LWC. Ototoxicity of common topical antimycotic preparations. Laryngoscope 2000;110:509-16.
7. Shiojima T, Ohki Y, Yako Y, et al. Immediate control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit. J Infect Chemother 2003;9:243-7.
8. Casewell MW, Hill RLR. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')-a controlled trial. J Antimicrob Chemother 1986;17:365-72.
9. Hayakawa T, Hayashidera T, Katsura S, et al. Nasal mupirocin treatment of pharynx-colonized methicillin-resistant Staphylococcus aureus: preliminary study with ten carrier infants. Pediatr Int 2000;42:67-70.
10. Spandow O, Anniko M, Moller AR. The round window as access route for agents injurious to the inner ear. Am J Otolaryngol 1988;100:134-6.
11. Pickett BP, Shinn JB, Smith MFW. Ear drop ototoxicity: reality or myth? Am J Otol 1997;18:782-91.